195 results on '"Carter, Barrie J."'
Search Results
2. Artificial miRNAs Mitigate shRNA-Mediated Toxicity in the Brain: Implications for the Therapeutic Development of RNAi
3. Parvovirus RNA Transcripts Containing Sequences not Present in Mature mRNA: A Method for Isolation of Putative mRNA Precursor Sequences
4. Stable in vivo Expression of the Cystic Fibrosis Transmembrane Conductance Regulator with an Adeno-Associated Virus Vector
5. Spliced Adenovirus-Associated Virus RNA
6. Vero Cells Injected with Adenovirus Type 2 mRNA Produce Authentic Viral Polypeptide Patterns: Early mRNA Promotes Growth of Adenovirus-Associated Virus
7. Eukaryotic Translational Control: Adeno-Associated Virus Protein Synthesis is Affected by a Mutation in the Adenovirus DNA-Binding Protein
8. Self-Complementarity of Terminal Sequences within Plus or Minus Strands of Adenovirus-Associated Virus DNA
9. Effect of gene therapy on visual function in Leber's congenital amaurosis
10. My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective
11. Adeno‐Associated Viral Vectors
12. [53] Adeno-associated virus vectors for gene therapy of cystic fibrosis
13. In Vivo Gene Therapy with Adeno-Associated Virus Vectors for Cystic Fibrosis
14. Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR
15. Adeno-Associated Virus Defectiveness and the Nature of the Adenovirus Helper Function
16. Variant and Defective Interfering Parvoviruses
17. Parvovirus Transcription
18. Authors' Response to Jesse D. Riordan, Hum Gene Ther 2017;28:375–376; DOI: 10.1089/hum.2017.045
19. AAV Infection: Protection from Cancer
20. Chapter 19 Parvoviridae
21. The Respiratory System as a Platform for Gene Delivery
22. Adeno-Associated Virus Vectors
23. Adeno-Associated Viral Vectors
24. Charting a Clear Path: The ASGCT Standardized Pathways Conference
25. Adeno-Associated Viral Vectors for Hereditary Emphysema; Progressing Along the Clinical Development Highway
26. CLINICAL DEVELOPMENT OF AAV VECTORS
27. Redox Modifier Genes and Pathways in Amyotrophic Lateral Sclerosis
28. Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
29. Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial
30. 414. Non-Allele Specific RNA Interference in the CAG140 Knock-In Mouse Model of Huntington's Disease
31. Correlation Between DNA Transfer and Cystic Fibrosis Airway Epithelial Cell Correction After Recombinant Adeno-Associated Virus Serotype 2 Gene Therapy
32. Adeno-Associated Virus Vectors in Clinical Trials
33. Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective
34. Workshop on Long-term Follow-up of Participants in Human Gene Transfer Research
35. AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice
36. Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study
37. Nonclinical Toxicology in Support of Licensure of Gene Therapies
38. CHAPTER 16: Gene Therapy and Viruses.
39. Venture Capital and Biotechnology Startups.
40. Lentiviral Vector Delivery of RNAi for the Treatment of HIV-1 Infection.
41. SV40 Virus-Derived Vectors.
42. Assays for Nonviral Vectors.
43. Gene Therapy for Cardiovascular Disease.
44. Lentivirus Vectors.
45. Immune Responses to Viral Vectors Injected Systemically or into the CNS.
46. Lentivirus Vector Manufacturing.
47. The Manufacture of Genetic Viral Vector Products.
48. Herpes Simplex Virus Vectors.
49. Assays for the Release of Cellular Gene Therapy Products.
50. Assays for the Quality Control of Lentiviral Vectors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.